WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
Cultural week celebrated at university to remind students of richness of Somali heritageRussia vetoes UN Security Council draft resolution on weapons of mass destruction in outer spaceMongolia suspends transfer of citizens due to parliamentary electionsBarcelona beat Real Sociedad to move secondLiaoning Leopards dominate Guangdong Tigers in CBA semifinals openerUS move of tariff hikes sets 'bad example' for free tradeUS tariff hikes on Chinese products bound to backfireGrand Canal exhibition in China showcases archaeological findingsOlympic flame arrives in Marseille amid tight securityBrazil halts top football league as flooding death toll rises
2.2052s , 4665.8984375 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Planet Pulse news portal